(Q36078760)

12 August 2017

1 reference

title

Alvimopan, a selective peripherally acting mu-opioid antagonist (English)

1 reference

12 August 2017

1 reference

M Camilleri

1

1 reference

12 August 2017

1 April 2005

1 reference

Neurogastroenterology and Motility

12 August 2017

1 reference

12 August 2017

17

1 reference

12 August 2017

2

1 reference

12 August 2017

157-165

1 reference

A multinational comparison of racecadotril and loperamide in the treatment of acute watery diarrhoea in adults

12 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Racecadotril in the treatment of acute watery diarrhea in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Opioid receptor expression in the rat gastrointestinal tract: a quantitative study with comparison to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

The opioid system in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Function of opioids in the enteric nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Peripheral opiate action on afferent fibres supplying the rat intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Preclinical studies of opioids and opioid antagonists on gastrointestinal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Irritable bowel syndrome patients show altered sensitivity to exogenous opioids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Naloxone treatment for irritable bowel syndrome--a randomized controlled trial with an oral formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Clinical perspective on postoperative ileus and the effect of opiates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Postoperative ileus: etiologies and interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Mechanisms of postoperative ileus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Increased tumor necrosis factor-alpha and nitric oxide production by rat macrophages following in vitro stimulation and intravenous administration of the delta-opioid agonist SNC 80.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Immunomodulation by opioid peptidomimetic compound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Insights into opioid action in the intestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Incidence, prevalence, and management of opioid bowel dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Oral naloxone reverses opioid-associated constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Discovery of a potent, peripherally selective trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonist for the treatment of gastrointestinal motility disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

ADL 8-2698, a trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Selective postoperative inhibition of gastrointestinal opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

Alvimopan∗∗Alvimopan is the official USAN name adopted as of press time. (ADL 8-2698) Is a Novel Peripheral Opioid Antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2005.00640.X

10.1111/J.1365-2982.2005.00640.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15787936